Two hundred sixty-two patients with 50% or greater obstruction of at least one coronary artery on the initial study underwent recatheterization 2-182 months later and were evaluated for progressive arterial changes. Progression was considered present if (1) a change from less than total obstruction to total obstruction occurred in any vessel; (2) a change from 70% or less to 90% or more occurred in any vessel; (3) a change from 30% or less to 50% or more occurred in any vessel not initially obstructed by 50%; or (4) a 20% or more increase in obstruction was noted in any vessel already narrowed 50% or more. Of the 262 patients, 116 of 238 men (49%) and 12 of 24 women (50%) met the criteria for progression. Risk factors determined at the time of the initial catheterization in patients who met the criteria for progression were compared with risk factors in patients who did not. No significant difference could be found between the groups in relation to family history, blood pressure, diabetes, smoking habits, weight, cholesterol levels, triglyceride values, initial ECG and initial catheterization findings.
CORONARY ATHEROSCLEROSIS is a degenerative arterial disease which in time can progress and produce vessel stenosis or occlusion, with reduced myocardial blood flow and myocardial damage or death.' Cardiac mortality has been related to the number of coronary arteries involved and to the amount of myocardial damage present at initial catheterization.2 Although several factors have been associated with coronary atherosclerosis and cardiac mortality,s their relation to progression of coronary atherosclerosis is not clear.4"1' Methods Three hundred thirty-five patients with coronary artery disease who underwent two cardiac catheterizations with coronary arteriography separated by 1 month or more were studied. Indications for recatheterization varied. Most often, persistent symptoms, a change of symptoms or an interval cardiac event led to restudy. In some cases, however, elective restudy was performed to determine if the disease had progressed. Patients with valvular disease or myocardial impairment unrelated to coronary atherosclerosis and patients who underwent open heart surgery between studies were excluded. Two hundred sixty-two patients of this group were selected for further study. All had at least one coronary artery obstruction of at least 50% luminal diameter at the initial catheterization. Seventy-three patients were excluded for separate analysis (no coronary lesion more than 50% in 36; left main trunk on the first study in 15; progression to left main trunk in two; and "regression" in 20).
The degree of coronary obstruction was determined by independent review of both studies by two angiographers. Their impressions were compared with each other and with the original chart diagnosis. The coronary arterial bed was divided-into 26 segments (right coronary artery, nine segments; left main trunk, three segments; left anterior descending, seven segments; and circumflex, seven segments), allowing obstructions to be coded by segments. A consensus and both cineangiograms were then presented to the senior angiographer for rereview and analysis in relation to clinical information stored in the Cardiovascular Information Registry of The Cleveland Clinic Foundation.
Analysis consisted of examining each artery (right coronary, left anterior descending and circumflex arteries) to find the most severe obstruction in that artery at the time of the first and second study. These obstructions were compared and progressive disease was considered present on the second study if one or more of the following criteria were met in relation to the artery or arteries initially identified as 50% or more obstructed: (1) a change from less than total obstruction to total obstruction in any artery; (2) a change from 70% or less to 90% or greater in any vessel.whether or not initially obstructed; (3) a change from 30% or less to 50% or greater in any vessel not initially obstructed by 50%; and (4) a 20% or more increase in obstruction in any vessel already narrowed 50% or more.
Each patient was eligible to meet criteria 1-4, in that order, without duplication, in any coronary artery not totally obstructed on the initial study. If none of the criteria was met on the second study, the patient was considered to have nonprogressive disease. Once divided into progressive and nonprogressive disease, the two groups were compared to determine the relation of risk factors to progression. Risk factors, as 519 determined by history, physical examination and laboratory examination, were obtained within a day or two of the initial catheterization. Differences between groups were analyzed by the nonpaired t test or the chi-square test. Results were considered significant by either method when p < 0.05.
Results

Group Characteristics
Of the 262 patients, 238 (91%) were men and 24 (9%) were women. Ages ranged from 29-68 years (mean 49 years).
One hundred forty-six patients (56%) had serum triglyceride values greater than 135 mg/dl and 97 patients (37%) had serum cholesterol levels greater than 250 mg/dl. A diastolic blood pressure more than 90 mm Hg was recorded in 70 patients (27%); a systolic blood pressure greater than 140 mm Hg was recorded in 110 patients (41%). Forty-eight patients (18%) had evidence of glucose intolerance and 138 patients (52.5%) were cigarette smokers. Sixty-one patients (23%) who weighed 20% or more above ideal body weight were considered obese. A family history of coronary artery disease was positive in 157 patients (60%).
At the time of the initial study, 84 patients (32%) had one vessel obstructed by 50% or more, 98 patients (37%) had two vessels obstructed, and 80 patients (31%) had three vessels obstructed. One hundred fifty patients (57%) had total occlusion of at least one vessel. One hundred twelve patients had normal ECGs, 76 (29%) had definite evidence of remote myocardial infarction and 74 patients (28%) had nonspecific electrocardiographic abnormalities.
Two hundred forty-three patients (93%) were recatheterized because of persistent symptoms, new symptoms or a significant recognized complication of coronary atherosclerosis subsequent to the first study. Nineteen (7%) were studied electively to determine if progressive changes had occurred (table 1).
The mean interval between studies was 36.5 months (range 2-182 months). One hundred thirty-four patients (51%) demonstrated no progression; 128 patients (49%) met the criteria for progression. One hun-dred seventy arteries (an average of 1.3 arteries per patient) changed (table 2).
One hundred sixteen of 238 men (49%) and 12 of 24 women (50%) showed progression. Progression patients, ages 29-68 years, tended to be younger than the nonprogression patients (p < 0.05). The mean interval between catheterizations was greater in patients that demonstrated progression (43.8 months) than in those who demonstrated no change (29.6 months) (p < 0.001) (table 3). The mean age (= SD) of patients with progression was less than those who did not progress (nonpaired t test, p < 0.05). The mean interval between studies (i SD) was greater in patients with progression than in those without (nonpaired t test, p < 0.001).
One-vessel progression occurred most frequently (71 %) regardless of the number of vessels involved initially. Progression in two vessels occurred less frequently (25%) and change in three vessels was rare (4%) (table 4). Knowledge of the initial pathology did not allow prediction of how many vessels would change, nor did it help in determining which vessel or combination of vessels would be involved (table 5) .
The number of patients who showed change on the second study is clearly related to the time between studies. The mean interval between studies was 14 months longer in patients who showed progression (p < 0.001). The probability of finding change increased as the interval between studies increased ( fig. 1 ). Although one-vessel progression was most frequent in each time interval, the probability of finding twoor three-vessel progression was greater if the patient was studied after an interval of 2 years ( fig. 2 ). Although the overall incidence of progression in the 262 patients was 49%, not all patients were at risk over the 10-year period. By counting patients only for the interval followed between catheterizations up to 10 years, 260 patients were followed for a total of 895 patient-years. One hundred twenty-six patients had progression during the 10 years, a progression rate of 14% per year.
Other factors including age, family history, blood pressure, diabetes, smoking habits, weight, cholesterol levels, triglyceride values, initial ECGs and number of arterial obstructions and occlusions at the time of the initial study were evaluated to determine if any would distinguish between patients who were to show progression and those who would not.
Age
The mean age of progression patients (47.9 ± 8.6 years) was younger than that of nonprogression patients (50.0 ± 7.4 years) (p < 0.05). The frequency of progression was greater in patients younger than 50 years than in those age 50 years or older. Seventythree patients (54%) of those younger than 50 years demonstrated progression, whereas only 55 patients (43%) of those 50 years and older demonstrated progression.
The factor of age, however, may not be independent of time. The mean interval between studies was 8.3 months greater in patients younger than 50 years of age (40.5 ± 30.3 months) than in those 50 years and older (32.2 ± 23.6 months). The difference between the means was statistically significant (nonpaired t test, p < 0.02), suggesting the greater frequency of progression in the younger age group was related to the longer interval between studies. tTwo vessels obstructed 50% or more. tThree vessels obstructed 50% or more. One hundred ninety-two patients (73%) had diastolic blood pressures less than 90 mm Hg at the initial study. Seventy (27%) had diastolic blood pressures greater than 90 mm Hg. No significant difference in the percentage of patients with progres-sion was noted between the groups with diastolic pressures above or below 90 mm Hg. In the group with diastolic pressures greater than 110 mm Hg, four patients showed progression and two did not. The numbers are too small, however, to make any statistically significant conclusion.
Patients with systolic blood pressures greater than 160 mm Hg showed more frequent progression. Again, however, the difference was not statistically significant (table 7) . (table 8) .
Smoking
One hundred one patients (38.5%) were nonsmokers and 138 (52.5%) were cigarette smokers at the time of the initial catheterization. The percentage of patients with progression was similar in the smoking and nonsmoking groups (table 9).
Weight
Obesity (weight greater than 20% over ideal body weight) did not identify patients who had progression. Two hundred one patients (77%) were not overweight, while 61 (23%) were overweight. The percentage of patients who showed progression was similar in each group (table 10) . 523 VOL 63, No 3, MARCH 1981 Lipids Serum triglyceride values were normal in 116 patients (44%) and abnormal in 146 patients (56%). The presence of abnormal triglyceride values and increased risk of progression were not related. Serum cholesterol levels were normal in 165 patients (63%) and abnormal in 97 patients (37%). The cholesterol level and frequency of progression were not related (table 11) .
Initial ECG and Catheterization Findings
An abnormal ECG at the initial catheterization was not related to an increased risk of progression (table 12) .
The frequency of progression was not related to the number of vessels involved 50% or more at the initial study or to the number of total occlusions present at the first catheterization (table 13) .
Effect of Arterial Progression
The clinically significant manifestation of arterial progression is end organ damage, i.e., increasing left ventricular impairment. Several measurements reflect changes of left ventricular function related to progression. Sixty-two patients had a transmural myocardial infarction between the first and second catheterizations confirmed by electrocardiography. Of these, 40 patients (65%) had evidence of progression by our criteria (p < 0.01) (table 14) . Left ventricular enddiastolic pressures were abnormal in 125 patients at the second catheterization. Of these, 70 patients (56%) met the criteria for progression (p < 0.05) (table 15 ).
In addition, at the second study, 85 patients had ventriculographic evidence of new or increased segmental impairment. Of these, 63-(74%) demonstrated progression of coronary atherosclerosis. The relation of progressive coronary atherosclerosis to the presence of new or increased segmental impairment was highly significant compared with patients with no progressive changes (p < 0.001) (table 16) . Total group 177 (68%) 85 (32%) Patients with progression were more likely to have new impairment than those who did not progress (chi-square test, p < 0.001).
Discussion
The angiographic analysis of progression is immensely complicated by the number of biases involved. Initially, the diagnostic accuracy of any cineangiogram depends on the capabilities of the angiographer and his ability to ensure high-quality diagnostic arteriography.'2 18 Sequential cineangiograms to study progression often involve two angiographers, and the diagnostic quality depends on the skill of both. Interpretation of the cineangiograms is another problem in the analysis of progression.14 Interobserver variability may allow the same patient to be classified as stable or changed. Using several reviewers and defining wide-spectrum criteria for progression is a partial solution (Bourassa MG: personal communication, March 1979). However, defining wide-spectrum criteria biases the study, because those who show marked progression are noted, but those who show subtle changes are not, favoring an underestimation of the progression rate, The nature of the disease itself introduces bias. Progressive disease may, in some patients, lead to death after the initial angiogram. Studies using sequential catheterizations to quantitate progression analyze survivors only, introducing a significant underestimation of the amount of progression occurring (Bruschke AVG: personal communication, April 1979). The study can be biased in the other direction, however, because the patient with changing symptoms is more likely to seek followup and is more likely to be recatheterized. This biases the study toward an overestimation of the rate of progression.
Gensini and Kelly' showed that progression could be detected angiographically, and noted the developmnent of significant arterial changes in 73 of 93 patients (78%) studied sequentially. The potential benefit of detecting significant arterial changes before total occlusion and irreversible myocardial damage was evident. The question became: Who should be restudied, and when should restudy be undertaken?
Significant identifying factors indicating the need for early restudy apparently are not known. Family history,"' 8. 10, 11 obesity," history of cigarette smoking,8' 1 hypertension, ' 10' 11 diabetes,s' 6, 10, 11 initial electrocardiographic findings5' 6, 8 and initial catheterization findings' 8, 10 have not been helpful as predictors of progression. Cholesterol levels"' 8 and triglyceride values8 have been related significantly to progression by some authors, but Rosch et al. 7 have found that a combination of risk factors must be present. In our group of patients, family history, blood pressure, diabetes, smoking habits, excessive body weight, cholesterol levels and triglyceride values as recorded at the time of the initial catheterization, and initial catheterization findings did not relate significantly to the presence of progressive arterial changes on the second study. They are not helpful in determining who should be restudied.
The younger patient may be more likely to show progressive changes at the second study. Bemis et al.8 noted more frequent progression in patients younger than 40 years, but the difference was not statistically significant. Marchandise et al." demonstrated more frequent progression in patients younger than 45 years with mild coronary atherosclerosis (p < 0.025). Our study confirms an increased frequency of progression in younger patients, but this may be related to the time between studies (p < 0.02).
Progression is clearly related to time (p < 0.001). Aggressive follow-up of any patient with coronary atherosclerosis is indicated. The disease is not static, but rather, is an actively progressive process. Valid therapeutic decisions and survival predictions made on the basis of angiographic findings at one point may not be reliable 1-2 years later. The long-term impact of coronary atherosclerosis depends on its propensity to become more severe with time, resulting in a progressive deterioration of left ventricular function. Patients with three-vessel disease and poor left ventricular contractility have a high mortality because there is little reserve against the progressive arterial and ventricular changes that occur. Patients with onevessel disease and normal left ventricular contractility survive longer primarily because of a greater reserve against the progressive changes. As two-and three-vessel disease develops, the prospects for complications and reduced survival change accordingly.
In our patients, 14% per year of the entire group demonstrated progressive changes. In 70 patients, at least one artery had become totally obstructed and 61 patients showed a progression to a critical stenosis (greater than 90%) in one or more coronary arteries. The changing coronary pathology was significantly related to increasing impairment of left ventricular function. 525 VOL 63, No 3, MARCH 1981 Active follow-up of patients with coronary atherosclerosis should be directed toward prevention of progressive myocardial damage by detecting progressive arterial changes in potentially bypassable coronary arteries before the development of the severely stenotic or occlusive lesions that lead to myocardial necrosis. A change in symptoms clearly indicates the need for restudy. Continued studies of patients who have undergone sequential catheterizations should result in the identification of reliable and easily determined prognosticators of progression, which will allow timely restudy of asymptomatic patients.
